These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38586200)
1. Molecular mechanism of formation and destruction of a pseudo‑capsule in clear cell renal cell carcinoma. Shimizu T; Miyake M; Iida K; Onishi S; Fujii T; Iemura Y; Ichikawa K; Omori C; Maesaka F; Tomizawa M; Miyamoto T; Tanaka N; Fujimoto K Oncol Lett; 2024 May; 27(5):225. PubMed ID: 38586200 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma. Rabjerg M Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890 [TBL] [Abstract][Full Text] [Related]
3. The Significance of Fibrosis Quantification as a Marker in Assessing Pseudo-Capsule Status and Clear Cell Renal Cell Carcinoma Prognosis. Qin C; Yin H; Liu H; Liu F; Du Y; Xu T Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33147753 [TBL] [Abstract][Full Text] [Related]
4. LZTS2: A novel and independent prognostic biomarker for clear cell renal cell carcinoma. Peng Y; Greenland NY; Lang UE; Stohr BA Pathol Res Pract; 2022 Apr; 232():153831. PubMed ID: 35287088 [TBL] [Abstract][Full Text] [Related]
5. Accuracy of magnetic resonance imaging to identify pseudocapsule invasion in renal tumors. Papalia R; Panebianco V; Mastroianni R; Del Monte M; Altobelli E; Faiella E; Grasso FR; Bellangino M; Simone G; Ciccozzi M; Angeletti S; D'ovidio G; Catalano C; Gallucci M; Scarpa RM; Muto G World J Urol; 2020 Feb; 38(2):407-415. PubMed ID: 31025082 [TBL] [Abstract][Full Text] [Related]
6. A prospective, multicenter analysis of pseudocapsule characteristics: Do all stages of renal cell carcinoma have complete pseudocapsules? Cho S; Lee JH; Jeon SH; Park J; Lee SH; Kim CH; Sung JY; Kim JH; Pyun JH; Lee JG; Kim JJ; Cheon J; Kang SG; Kang SH Urol Oncol; 2017 Jun; 35(6):370-378. PubMed ID: 28188091 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma. Fan B; Wang W; Zhang X; Sun M; Wang X; Chen Z; Liu W; Wang Q; Yu N; Li X BMC Cancer; 2019 Jun; 19(1):534. PubMed ID: 31159774 [TBL] [Abstract][Full Text] [Related]
8. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis. Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis. Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910 [TBL] [Abstract][Full Text] [Related]
10. Tumor volume: a new prognostic factor of oncological outcome of localized clear cell renal cell carcinoma. Chen SH; Xu LY; Wu YP; Ke ZB; Huang P; Lin F; Li XD; Xue XY; Wei Y; Zheng QS; Xu N BMC Cancer; 2021 Jan; 21(1):79. PubMed ID: 33468079 [TBL] [Abstract][Full Text] [Related]
11. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway. Deng H; Gong X; Ji G; Li C; Cheng S Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of peritumoral pseudocapsule in small renal cell carcinoma and its influencing factors. Dong X; Pan S; Zhou X; Ma W; Guo H; Gan W Cancer Med; 2023 Jan; 12(2):1260-1268. PubMed ID: 35766142 [TBL] [Abstract][Full Text] [Related]
14. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway. Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma. Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867 [TBL] [Abstract][Full Text] [Related]
16. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management. Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of FoxM1 is associated with tumor progression in patients with clear cell renal cell carcinoma. Xue YJ; Xiao RH; Long DZ; Zou XF; Wang XN; Zhang GX; Yuan YH; Wu GQ; Yang J; Wu YT; Xu H; Liu FL; Liu M J Transl Med; 2012 Sep; 10():200. PubMed ID: 23006512 [TBL] [Abstract][Full Text] [Related]
18. Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival. Qiang Y; Wang X; Ding J; Wang Z; Li B; Ji H; Zhang X; Yang Y; Liu K; Zhang L; Ma S; Zhao D; Lu G Clin Genitourin Cancer; 2023 Apr; 21(2):e78-e91. PubMed ID: 36127253 [TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway. Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137 [TBL] [Abstract][Full Text] [Related]
20. Expression of functional E-selectin ligands on the plasma membrane of carcinoma cells correlates with poor prognosis in clear cell renal cell carcinoma. Tanio M; Muramoto A; Hoshino H; Murahashi M; Imamura Y; Yokoyama O; Kobayashi M Urol Oncol; 2021 May; 39(5):302.e9-302.e18. PubMed ID: 33676847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]